Streetbeat News

Stock Prices

KDP

Keurig Dr Pepper's short interest has decreased by 5.53%, with 21.72 million shares sold short, representing 2.05% of its float. This is lower than its peers' average short interest of 7.16%. The decrease in short interest may indicate a more bullish sentiment towards the stock.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 8:45 pm

ENSC

Ensysce Biosciences, Inc. (NASDAQ:ENSC) has received a notice from Nasdaq indicating non-compliance with listing requirements due to its stock price remaining below $1.00 and not meeting the minimum stockholders' equity requirement. The company is not eligible for an additional 180-day compliance period, and its continued listing will be reviewed by the Nasdaq Hearings Panel.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:35 pm

GMM

Global Mofy AI Limited has received a notification from Nasdaq regarding its failure to meet the minimum closing bid price requirement. This could lead to potential delisting if the issue is not resolved.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:35 pm

JNJ

Johnson & Johnson's CARVYKTI, a cell therapy, has shown a 45% reduction in the risk of death for multiple myeloma patients in the CARTITUDE-4 study, making it the first therapy to significantly extend overall survival compared to standard treatments.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:33 pm

NYXH

Nyxoah presented data from its DREAM pivotal study at the International Surgical Sleep Society 2024, showing a 71% median reduction in Apnea-Hypopnea Index for patients with Obstructive Sleep Apnea. The study also reported significant improvements in quality-of-life outcomes.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:32 pm

PSTX

Poseida Therapeutics has reported interim results from its Phase 1 trial of the allogeneic CAR-T therapy P-BCMA-ALLO1, showing a 91% overall response rate (ORR). This promising result could have positive implications for the company's future prospects in the CAR-T therapy market.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 8:32 pm

BAOS

BREA

GIFT

HWH

JFU

SNAL

Several communication services stocks experienced significant price movements in Friday's after-market session. Notable gainers included RDE, Snail, and Baosheng Media, while 9F, HWH International, and Brera Holdings were among the losers.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 8:31 pm

NEE

NextEra Energy (NYSE:NEE) has delivered an average annual return of 13.09% over the past 15 years, outperforming the market by 1.06% annually. A $100 investment in NEE 15 years ago would be worth $635.28 today, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 8:31 pm

ESLA

EYEN

GANX

IGC

OPTN

TCBP

Several healthcare stocks experienced significant price movements in Friday's after-market session. Notable gainers included IGC Pharma, TC BioPharm, and OptiNose, while Gain Therapeutics, Estrella Immunopharma, and Eyenovia were among the losers.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 8:31 pm

PANW

Palo Alto Networks (NASDAQ:PANW) has significantly outperformed the market over the past decade, with an average annual return of 26.22%. A $100 investment in PANW 10 years ago would be worth $1,055.93 today, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 8:31 pm